Quick Hits: Robinson, Andrus, Profar, Appel

Sixty-six years ago today, Jackie Robinson broke baseball's color barrier when he made his Major League debut for the Brooklyn Dodgers. After an 0-for-3 debut, Robinson went on to hit .297/.383/.427 with 12 home runs, a league-leading 29 stolen bases and won Rookie of the Year honors. As MLB.com's Richard Justice writes, the movie "42" introduces Robinson to a new generation of Americans and helps to immortalize the legacy of one of America's most courageous figures: "Robinson paid an incomprehensible price in the pain he endured and the responsibility he carried," writes Justice.

Baseball as we know it would not be the same were it not for Robinson's courage, talent and perseverance. Here's a look at some news from around the league on Jackie Robinson day…

• In his latest MLB.com mailbag, T.R. Sullivan writes that the Elvis Andrus extension, while risky for the Rangers, is still beneficial to the team. He credits Scott Boras for "astutely putting risk" on Texas.
• Within that same piece, Sullivan writes that the Rangers would trade a package of prospects highlighted by Jurickson Profar "in the blink of an eye" if it meant landing David Price from the Rays or Giancarlo Stanton from the Marlins.
• Jim Callis of Baseball America feels that Mark Appel has plenty of leverage in the upcoming draft and will likely sign a bonus in the $6MM neighborhood. As Callis notes, teams can't risk offering something like a $5MM "take it or leave it" offer and signing the rest of their picks. Doing so could ultimately lead to paying over slot to sign Appel, costing them future picks. It's in the best interest of whoever drafts Appel to sign him first, and doing so could prove highly expensive.
• Callis also notes that Appel and Oklahoma right-hander Jonathan Gray have established themselves as the clear-cut top two prospects in the draft.
• Major League Baseball is making progress on its investigation of the Biogenesis scandal, writes Jon Heyman of CBS Sports. However, it appears MLB is looking for "a smoking gun" before taking what could be its only chance to question players such as Alex Rodriguez and Ryan Braun who have been connected to the Miami clinic. Heyman confirms that MLB has purchased Biogenesis documentation, but notes that the MLBPA will be sure to question documents that were produced after a cash transaction.